Ranked above it

CoreAge Rx
One price per compound that covers every dose — and no pharmacy named on the site.
#1 on our sermorelin provider ranking, above Kin Meds at #56.
Read the CoreAge Rx review →
Provider review
Its FAQ names one "exclusive" pharmacy; its Returns Policy ships from a different one.
Kin Meds' FAQ says it "works exclusively with Rush Pharmacy" (rushpharmacy.com, Oviedo, FL) — but its own Returns and Refund Policy separately lists the return address for the same prescription products as "Kin Meds/Strive Pharmacy" (Gilbert, AZ), a real, live, unedited contradiction about who actually fills the order.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What Kin Meds discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

CoreAge Rx
One price per compound that covers every dose — and no pharmacy named on the site.
#1 on our sermorelin provider ranking, above Kin Meds at #56.
Read the CoreAge Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not disclosed
Prices read from Kin Meds's own site · August 2026
What they advertise
Kin Meds' own GLP-1/GIP page headlines "Starts At $249" for its Personalized GLP-1/GIP (tirzepatide) product, a "30-day supply of the medication," with a flat "Same Price. Every Dose" claim printed beside it — no dose tiers found anywhere on the page. Its own GLP-1 page separately headlines "Personalized GLP-1" (a formulation its own copy confirms "contains semaglutide," combined with B12) at "$199" — and, on that same page, states a direct 503(A) compounding-pharmacy category, a claim neither the FAQ nor the Returns and Refund Policy repeats.
What you actually pay
$249/month (GLP-1/GIP) and $199/month (semaglutide-containing GLP-1) are recorded here as the standing recurring charges, consistent with the pages' own "30-day supply... shipped every 30 days" cadence language and the absence of any separate membership fee or intro-price footnote anywhere on the site. It could not independently confirm either figure against Kin Meds' own live checkout: the "Take Quiz" funnel (quiz.kinmeds.com) is a separate booking app that shows no price when it first loads, and it could not be unavailable this session to walk it interactively — the same verification-limitation shape as Viv Health's review. Sermorelin is $349 a month.
Money you will meet later
Kin Meds (Manhattan Beach, CA) is a live, operating telehealth company selling compounded tirzepatide, compounded semaglutide, branded GLP-1 referrals (Wegovy, Zepbound, Foundayo), a sermorelin injection, NAD+, glutathione, and TRT. Nothing here rises to what got MEDVi excluded from this site outright — documented deepfaked patient photos and fabricated physician personas. No independent journalism names Kin Meds beyond syndicated coverage of its own FDA letter. It also names no individual physician anywhere, only an "independent licensed physician network" — so unlike Viv Health, whose two named doctors both resolve in the CMS NPI Registry, Kin Meds offers no clinician to look up at all. The FDA letter's own addressee address matches the address Kin Meds publishes site-wide, a real operating company at the address FDA mailed it to. That clears the bar this site draws between a disclosable knock and a disqualifying one. What remains: a real, dated FDA warning letter (MARCS-CMS 721450, February 20, 2026) over a mislabeled-compounder claim plus two separately-cited marketing claims implying FDA approval, and — found independently of that letter — a real, live contradiction on Kin Meds' own site about which pharmacy actually fills a prescription.
Kin Meds appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Kin Meds does not name the pharmacy that fills your prescription.
Unknown category, and internally contradicted. Kin Meds' own FAQ names one pharmacy directly and states it works "exclusively" with it (Rush Pharmacy, rushpharmacy.com, Oviedo, FL) — but its own Returns and Refund Policy gives a SECOND, different pharmacy's address as the return destination for the same prescription products (Kin Meds/Strive Pharmacy, Gilbert, AZ). Neither "503A" nor "503B" appears anywhere checked (About, FAQ, Terms of Use, Returns and Refund Policy, HIPAA Notice, or Privacy Policy) — only vague category language ("sourced from trusted American pharmacies," "US partner pharmacies").
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Not published as a list. Kin Meds' own FAQ states only, "We have nationwide coverage. If in doubt about a specific territory, please reach out" — a hedge, not a comprehensive list and not an plain "all 50 states" claim. No exclusion list appears anywhere on the site.
The part they would rather you skipped
FDA issued Kin Meds a warning letter (MARCS-CMS 721450, February 20, 2026, Center for Drug Evaluation and Research), addressed to 1590 Rosecrans Ave, Manhattan Beach, CA 90266 — the identical address confirmed against Kin Meds' own site-wide page data. The letter states FDA reviewed kinmeds.com in December 2025 and found the compounded semaglutide and tirzepatide products displayed on the site identified "Kin Meds" on the pictured label, suggesting Kin Meds is the compounder of those drugs when in fact it is not — misbranded under FDCA §§502(a) and 502(bb). Separately, and cited independently in the same letter, FDA named two specific marketing claims it says implied FDA approval or safety evaluation that never occurred: "Same Active Ingredient as common brands," and "Hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medications, at a fraction of the cost" — the same two-separately-cited-claims shape as BluefitMD's letter from the identical wave. Neither quoted phrase appears on the live site today, consistent with post-letter remediation — the same pattern already documented for Strut Health. Independent of the letter, Kin Meds' own site contradicts itself about which pharmacy fills a prescription: its own FAQ states, "Kin Meds works exclusively with Rush Pharmacy" — but its own Returns and Refund Policy lists TWO different "Address for Returns" blocks for what should be the same prescription-medication flow: one for "Kin Meds / Rush Pharmacy" (1977 Alafaya Trail #1121, Oviedo, FL) and, separately on the same page, one for "Kin Meds/Strive Pharmacy" (1275 E Baseline Rd #104, Gilbert, AZ) — an unresolved, unedited contradiction of the exact "exclusively" claim made elsewhere on the same site. Also independent of the FDA letter: Kin Meds' own Terms of Use state the agreement is "governed by and construed in accordance with the laws of the State of Georgia" in its Governing Law clause, then state two clauses later that any dispute goes to "binding arbitration in San Diego, California" where "the arbitrator will apply the law in accordance with the laws of the State of California" — a real split between which state's law the Terms name as governing and which state's law an arbitrator would actually apply, the same shape (if a smaller one) as Ivim Health's Michigan-vs-Ohio jurisdiction contradiction already here.
None of this is unique to Kin Meds — the whole category shares it.
The providers we rank on our sermorelin provider ranking — the most specific board Kin Meds sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.





66 more providers rank on our sermorelin provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Kin Meds's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Kin Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Kin Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Kin Meds
3 compounds from $199/mo